A Contextual-Bandit-Based Approach for Informed Decision-Making in Clinical Trials

Area of Science:

• Machine Learning
• Clinical Trials
• Biostatistics

Background:

• Clinical trials traditionally use randomization for unbiased treatment evaluation, but this can lead to suboptimal patient outcomes.
• Supervised learning methods in post hoc analyses require large, randomized datasets and may not adapt to individual patient needs.
• Existing reinforcement learning methods, like multi-arm bandits, often assume homogeneous patient populations, failing to account for individual variability.

Purpose of the Study:

• To develop and evaluate a novel contextual-bandit algorithm for online treatment optimization in clinical trials.
• To enhance treatment assignment by incorporating patient characteristics alongside outcome maximization.
• To improve upon existing methods by dynamically adapting treatment allocation during a trial.

Main Methods:

• A contextual-bandit algorithm was developed to personalize treatment selection based on patient characteristics.
• The algorithm was evaluated retrospectively on the International Stroke Trial dataset, simulating an online setting.
• Treatment assignments were compared using random choice, Thompson sampling, and UCB-based approaches within a contextual-bandit framework.

Main Results:

• The proposed contextual-bandit approach demonstrated significant improvements over random assignment and context-free multi-arm bandits.
• The contextual-bandit approach achieved a 72.63% gain in assigning suitable treatments compared to random assignment.
• A context-free multi-arm bandit approach showed a 64.34% gain over random assignment, highlighting the benefit of context-awareness.

Conclusions:

• Contextual-bandit algorithms offer a superior approach to treatment assignment in clinical trials compared to traditional randomization and context-free methods.
• Personalizing treatment decisions by incorporating patient characteristics can substantially increase the proportion of patients receiving the most effective interventions.
• This adaptive online learning strategy holds promise for optimizing clinical trial outcomes and improving patient care.